Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
Status:
Withdrawn
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out what effects, good and bad, the chemotherapy drugs
gemcitabine (Gemzar) and paclitaxel (Taxol) have in combination with twice daily radiation
treatment on locally advanced pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
New York Methodist Hospital New York Presbyterian Brooklyn Methodist Hospital